| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/03/2011 | CN101791378B Traditional Chinese medicine preparation for wound hemostasis, anti-inflammatory and tissue regeneration |
| 08/03/2011 | CN101787000B M-stage kinesin inhibitor |
| 08/03/2011 | CN101780090B Tablet containing valsartan and hydrochlorothiazide |
| 08/03/2011 | CN101773579B Chinese medicine for treating hemorrhoids and constipation |
| 08/03/2011 | CN101766705B Medicinal combination containing borneol and musk |
| 08/03/2011 | CN101766704B Medicinal combination containing borneol and musk |
| 08/03/2011 | CN101766700B Medicinal combination containing musk |
| 08/03/2011 | CN101664476B Medicinal pillow |
| 08/03/2011 | CN101642521B Medicine for treating cerebral apoplexy hemiplegy sequela |
| 08/03/2011 | CN101627997B 3-amino-1-nitro-guanyl-2-piperidones and application of salts thereof in preparation of medicines for treating cardiovascular diseases |
| 08/03/2011 | CN101618207B Application of polypeptide in preparing ACE inhibitor and medicine for lowering blood pressure |
| 08/03/2011 | CN101574472B Medicament for treating hyperpiesis and preventing complications |
| 08/03/2011 | CN101496798B Use of salvianolic acid B |
| 08/03/2011 | CN101411742B Capsule for freeing collateral vessels containing astragalus and leech |
| 08/03/2011 | CN101371876B Method for extracting and preparing total polysaccharide of compound abnormal savda mature agent |
| 08/03/2011 | CN101293055B Scutellaria health tea and its processing method |
| 08/03/2011 | CN101184756B Isoflavonoid dimers |
| 08/03/2011 | CN101143861B B ring 4'-single substituted flavone compounds, preparation method and use |
| 08/02/2011 | US7989661 Human ADAM-10 inhibitors |
| 08/02/2011 | US7989650 Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
| 08/02/2011 | US7989585 Chronic treatment regimen using glucagon-like insulinotropic peptides |
| 08/02/2011 | US7989490 Injectable formulations of taxanes for cad treatment |
| 08/02/2011 | US7989478 Cinnamoyl compound and use of the same |
| 08/02/2011 | US7989452 Sterile injectible solution of drug in solvent or diluent |
| 08/02/2011 | US7989427 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 08/02/2011 | US7989424 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 08/02/2011 | US7989210 IL1RL-1 as a cardiovascular disease marker and therapeutic target |
| 08/02/2011 | US7989182 Nucleic acid encoding SCN1A variant |
| 08/02/2011 | US7988956 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 08/02/2011 | CA2667966C Pyrazoline compounds as mineralocorticoid receptor antagonists |
| 08/02/2011 | CA2489209C New derivatives of arylsulfonamides and use thereof in therapy |
| 08/02/2011 | CA2488242C Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
| 08/02/2011 | CA2479109C Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 08/02/2011 | CA2458025C Novel 4-aminofuropyrimidines and the use thereof |
| 08/02/2011 | CA2449634C Somatostatin-dopamine chimeric analogs |
| 08/02/2011 | CA2447632C Fusion protein agonist comprising a growth hormone binding portion and an external domain of a growth hormone receptor |
| 08/02/2011 | CA2395593C Azaindoles |
| 08/02/2011 | CA2323207C Food products having enhanced cocoa polyphenol content and processes for producing same |
| 07/28/2011 | WO2011091366A2 Methods of treating or preventing periodontitis and diseases associated with periodontitis |
| 07/28/2011 | WO2011091167A2 Lysophosphatidic acid receptor targeting for scleroderma and other fibrotic diseases |
| 07/28/2011 | WO2011090929A1 Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents |
| 07/28/2011 | WO2011090062A1 Piperazine compound having a pgds inhibitory effect |
| 07/28/2011 | WO2011089234A2 Method and composition |
| 07/28/2011 | WO2011089168A2 Special composition for the use thereof as a drug |
| 07/28/2011 | WO2011089161A1 Pharmaceutical compositions comprising lignans and their derivatives for the medical management of angiogenesis and hypovascularity |
| 07/28/2011 | WO2011089152A1 Methods and pharmaceutical composition for the preservation of vascular endothelial cell barrier integrity |
| 07/28/2011 | WO2011088837A1 Treatment of cardiac conditions |
| 07/28/2011 | WO2011088688A1 Polymer micelle medicine carrier comprising amino acid as stabilizer |
| 07/28/2011 | WO2011056037A9 Pharmaceutical composition containing, as active ingredients, lindera erythrocarpa extracts, fractions thereof, or compounds separated from the extracts |
| 07/28/2011 | WO2011038152A3 Toll-like receptor modulators and uses thereof |
| 07/28/2011 | US20110185439 G protein coupled receptors and uses thereof |
| 07/28/2011 | US20110184494 Method and apparatus for stimulating the sphenopalatine ganglion to modify properties of the BBB and cerebral blood |
| 07/28/2011 | US20110184330 Inactivation of smooth muscle tissue |
| 07/28/2011 | US20110184220 Methods for the treatment of radiation or chemotherapy-induced tissue damage |
| 07/28/2011 | US20110184048 Uses and Compositions Comprising miRNAs |
| 07/28/2011 | US20110184047 Rnai modulation of scap and therapeutic uses thereof |
| 07/28/2011 | US20110184038 Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 07/28/2011 | US20110184034 Severe sepsis preventive therapeutic agent |
| 07/28/2011 | US20110184032 Novel Phenylamino Isonicotinamide Compounds |
| 07/28/2011 | US20110184027 Tissue selective stearoyl-coa desaturase 1 inhibitors and cell based screening assay for their identification |
| 07/28/2011 | US20110184020 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process For Making Them, and Use Thereof For Treating Pain and Other Conditions |
| 07/28/2011 | US20110183999 Novel polymorphic forms of methyl carbamate |
| 07/28/2011 | US20110183997 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 07/28/2011 | US20110183994 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 07/28/2011 | US20110183991 5ht7 receptor ligands and compositions comprising the same |
| 07/28/2011 | US20110183990 Method of treating atrial fibrillation |
| 07/28/2011 | US20110183986 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/28/2011 | US20110183977 Benzene, pyridine, and pyridazine derivatives |
| 07/28/2011 | US20110183965 6-aminoisoquinoline compounds |
| 07/28/2011 | US20110183961 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 07/28/2011 | US20110183955 2-Aminocarbonyl Substituted Piperazine or Diaza-Cyclic Compounds as Apoptosis Protein Inhibitors (Iap) Modulators |
| 07/28/2011 | US20110183951 Copper (1) Complex |
| 07/28/2011 | US20110183948 Treatment of fibrotic conditions using hedgehog inhibitors |
| 07/28/2011 | US20110183947 Alpha-keto heterocycles as faah inhibitors |
| 07/28/2011 | US20110183935 Heartwater |
| 07/28/2011 | US20110183930 Water soluble and activable phenolics derivatives with dermocosmetic and therapeutic applications and process for preparing said derivatives |
| 07/28/2011 | US20110183929 Standardized extract and fraction from hancornia speciosa leaves and pharmaceutical composition thereof |
| 07/28/2011 | US20110183928 3-Cyanoalkyl- and 3-hydroxyalkylindoles and use thereof |
| 07/28/2011 | US20110183927 Compositions Comprising Sugar-Cysteine Products |
| 07/28/2011 | US20110183911 Method for improving neurotransmission failure using a novel agent |
| 07/28/2011 | US20110183890 Methods for modulating angiogenesis via dystrophin dp71 |
| 07/28/2011 | US20110183889 Salicylanilide modified peptides for use as oral therapeutics |
| 07/28/2011 | US20110183886 Melanocortin receptor ligands |
| 07/28/2011 | US20110183010 Cardioplegic preparation |
| 07/28/2011 | US20110182998 Microspheres useful for therapeutic vascular embolization |
| 07/28/2011 | US20110182989 Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to rgd binding sites |
| 07/28/2011 | US20110182983 Human immortalised neural precursor cell line |
| 07/28/2011 | US20110182964 Vascular Stent Which Elutes Amino Acid-Methyl-Ester Derivatives for the Treatment of Vulnerable Plaque and Vascular Disease |
| 07/28/2011 | US20110182899 Anti-glycoptrotein vi scfv fragment for treatment of thrombosis |
| 07/28/2011 | US20110182895 Antibody variants |
| 07/28/2011 | US20110182893 Prevention and treatment of amyloidogenic diseases |
| 07/28/2011 | US20110182883 Novel gene disruptions, compositions and methods relating thereto |
| 07/28/2011 | US20110182876 Methods of Treatment with Elastase |
| 07/28/2011 | US20110182866 Isolation of stem cell precursors and expansion in non-adherent conditions |
| 07/28/2011 | US20110182851 Oxidized ldl specific antibody-fusion and conjugated proteins |
| 07/28/2011 | US20110182819 Methods and Compounds for Promoting Vessel Regression |
| 07/28/2011 | US20110182817 Antibody against calcified globule and use of the same |
| 07/28/2011 | US20110182816 ANTIBODY AGAINST OXIDIZED LDL/ß2GPI COMPLEX AND USE OF THE SAME |
| 07/28/2011 | US20110182805 Nanoparticle fabrication methods, systems, and materials |
| 07/28/2011 | DE102010005953A1 Verfahren zur Herstellung von Nebivolol Process for the preparation of nebivolol |